Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q2 2014 · 10-Q
Revenue$934.00K$934.00K−29.3% vs Q2 2013 Net income—
EPS Diluted-$0.57-$0.57N/M vs Q2 2013 Operating Income-$9,794,000N/M Operating Cash Flowderived-$54,405,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Free Cash Flowderived-$53,341,000N/M Margins · derivedOperating margin-1048.6%+2112.2 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 7, 2014 · 38 d after period end